First Trust Advisors’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-41,504
Closed -$1.79M 2374
2015
Q3
$1.79M Sell
41,504
-13,038
-24% -$550K 0.01% 1447
2015
Q2
$2.31M Buy
54,542
+26,107
+92% +$1.1M 0.01% 1445
2015
Q1
$1.1M Buy
28,435
+5,800
+26% +$223K ﹤0.01% 1720
2014
Q4
$762K Buy
22,635
+7,654
+51% +$270K ﹤0.01% 1831
2014
Q3
$525K Sell
14,981
-1,345
-8% -$46.1K ﹤0.01% 1911
2014
Q2
$536K Sell
16,326
-11,132
-41% -$381K ﹤0.01% 1884
2014
Q1
$1.01M Buy
27,458
+2,373
+9% +$87.1K ﹤0.01% 1682
2013
Q4
$963K Buy
25,085
+7,269
+41% +$229K ﹤0.01% 1651
2013
Q3
$488K Sell
17,816
-1,145
-6% -$27.1K ﹤0.01% 1921
2013
Q2
$398K Buy
+18,961
New +$370K ﹤0.01% 1917

Other funds holding WX

First Trust Advisors's WX Position: Q4 2015 in Review

First Trust Advisors sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 41,504 shares — an estimated $1.79M sold.

First Trust Advisors first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $2.31M in Q2 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • First Trust Advisors reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • First Trust Advisors sold 41,504 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $1.79M.
  • First Trust Advisors first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
  • First Trust Advisors's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $2.31M in Q2 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on First Trust Advisors's 13F filing for Q4 2015, filed 3 Feb 2016.